Pediatric Diabetes

Papers
(The TQCC of Pediatric Diabetes is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
COVID ‐19 outbreak and pediatric diabetes: Perceptions of health care professionals worldwide86
Diabetic ketoacidosis at type 1 diabetes diagnosis in children during theCOVID‐19 pandemic73
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state62
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes55
Racial disparities in treatment and outcomes of children with type 1 diabetes51
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery48
Children and youth with diabetes are not at increased risk for hospitalization due to COVID ‐1946
Glucose management for exercise using continuous glucose monitoring ( CGM ) and intermittently scanned CGM ( isCG45
ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents44
ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents42
Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance41
Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed ™ 670G system trial38
ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents38
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring36
ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents35
Pre‐school and school‐aged children benefit from the switch from a sensor‐augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis32
ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in children and adolescents with diabetes32
Telemedicine and COVID ‐19 pandemic: The perfect storm to mark a change in diabetes care. Results from a world‐wide cross‐sectional web‐based survey30
Sleep and diabetes‐specific psycho‐behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents29
ISPAD Clinical Practice Consensus Guidelines 2022: Psychological care of children, adolescents and young adults with diabetes28
Outcomes of monthly video consultations as an add‐on to regular care for children with type 1 diabetes: A 6‐month quasi‐randomized clinical trial followed by an extension phase28
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in adolescence27
ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes26
Continuous glucose monitoring for hypoglycaemia in children: Perspectives in 202026
Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID ‐19 pandemic in Israel26
ISPAD Clinical Practice Consensus Guidelines 2022: Nutritional management in children and adolescents with diabetes25
A high potency multi‐strain probiotic improves glycemic control in children with new‐onset type 1 diabetes mellitus: A randomized, double‐blind, and placebo‐controlled pilot study25
Significant reduction of ketoacidosis at diabetes onset in children and adolescents with type 1 diabetes—The Stuttgart Diabetes Awareness Campaign, Germany24
Early markers of periodontal disease and altered oral microbiota are associated with glycemic control in children with type 1 diabetes24
Diabetes distress and HbA1c in racially/ethnically and socioeconomically diverse youth with type 1 diabetes24
Worse glycemic control, higher rates of diabetic ketoacidosis, and more hospitalizations in children, adolescents, and young adults with type 1 diabetes and anxiety disorders23
Dasiglucagon, a next‐generation ready‐to‐use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial23
Association between fear of hypoglycemia and physical activity in youth with type 1 diabetes: The SEARCH for diabetes in youth study22
Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity22
Diabetes and cardiometabolic risk in South Asian youth: A review21
Type 2 diabetes in prepubertal children21
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID ‐19 and resource‐limited settings‐role of subcutaneous insulin21
Increase in newly diagnosed type 1 diabetes in youth during the COVID ‐19 pandemic in the United States : A multi‐center analysis21
ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes20
ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes20
Daily variations in sleep and glucose in adolescents with type 1 diabetes20
Population‐level management of type 1 diabetes via continuous glucose monitoring and algorithm‐enabled patient prioritization: Precision health meets population health19
Brain injury in children with diabetic ketoacidosis: Review of the literature and a proposed pathophysiologic pathway for the development of cerebral edema19
Socioeconomic position is associated with glycemic control in youth and young adults with type 1 diabetes18
Changes to care delivery at nine international pediatric diabetes clinics in response to the COVID ‐19 global pandemic18
Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype18
Cardiovascular risk factors in children and adolescents with type 1 diabetes in Italy: a multicentric observational study18
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes education in children and adolescents17
Challenges in the diagnosis of diabetes type in pediatrics17
Rapid increases in observed incidence and prevalence of Type 1 diabetes in children and youth in Mali, 2007–201617
ISPAD Clinical Practice Consensus Guidelines 2022: Management of cystic fibrosis‐related diabetes in children and adolescents17
Long‐term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration17
HLA‐DR‐DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity16
Defining features of diabetes resilience in emerging adults with type 1 diabetes16
Time trends in incidence of diabetes mellitus in Austrian children and adolescents <15 years (1989‐2017)16
Self‐reported insulin pump prescribing practices in pediatric type 1 diabetes16
Incidence of type 1 diabetes in 0 to 14 year olds in Australia from 2002 to 201716
Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial16
High prevalence of idiopathic (islet antibody‐negative) type 1 diabetes among Indian children and adolescents15
First year on commercial hybrid closed‐loop system—experience on 111 children and adolescents with type 1 diabetes15
In vivo confocal microscopy study of corneal nerve alterations in children and youths with Type 1 diabetes15
COVID ‐19 vaccination in adolescents and young adults with type 1 diabetes: Glycemic control and side effects15
Comprehensive psychosocial screening in a pediatric diabetes clinic15
The role of parental support for emerging adults with type 1 diabetes: A scoping review14
Association of the use of diabetes technology withHbA1candBMI‐SDSin an international cohort of children and adolescents with type 1 diabetes: TheSWEETproject experienc14
Prevalence and course of mood and anxiety disorders, and correlates of symptom severity in adolescents with type 1 diabetes: Results from diabetes LEAP14
Previous diabetic ketoacidosis as a risk factor for recurrence in a large prospective contemporary pediatric cohort: Results from the DPV initiative14
The efficacy and safety of insulin pump therapy with predictive low glucose suspend feature in decreasing hypoglycemia in children with type 1 diabetes mellitus: A systematic review and meta‐analysis14
Metabolic control during the SARS‐CoV ‐2 lockdown in a large German cohort of pediatric patients with type 1 diabetes: Results from the DPV 14
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin14
Financial stress in emerging adults with type 1 diabetes in the United States14
The association between depression symptom endorsement and glycemic outcomes in adolescents with type 1 diabetes14
Nutrition habits of children and adolescents with type 1 diabetes changed in a 10 years span14
High prevalence of disordered eating behavior in Danish children and adolescents with type 1 diabetes14
β‐cells in youth with impaired glucose tolerance or early type 2 diabetes secrete more insulin and are more responsive than in adults13
Delayed referral is common even when new‐onset diabetes is suspected in children. A Swedish prospective observational study of diabetic ketoacidosis at onset of Type 1 diabetes13
Left atrial dysfunction and stiffness in pediatric and adult patients with Type 1 diabetes mellitus assessed with speckle tracking echocardiography13
ISPADClinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes13
Pediatric diabetes and skin disease ( PeDiSkin ): A cross‐sectional study in 369 children, adolescents and young adults with type 13
Association of obesity phenotypes in adolescents and incidence of early adulthood type 2 diabetes mellitus: Tehran lipid and glucose study13
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes13
ISPAD Clinical Practice Consensus Guidelines 2022: Managing diabetes in preschoolers13
A decade of improved glycemic control in young children with type 1 diabetes: A population‐based cohort study13
Metabolomics‐related nutrient patterns at seroconversion and risk of progression to type 1 diabetes12
Eukaryotic viruses in the fecal virome at the onset of type 1 diabetes: A study from four geographically distant African and Asian countries12
Prevalence of dyslipidemia in Indian children with poorly controlled type 1 diabetes mellitus12
Clinical profile and incidence of microvascular complications of childhood and adolescent onset type 1 and type 2 diabetes seen at a tertiary diabetes center in India12
Digital health interventions for improving mental health outcomes and wellbeing for youth with type 1 diabetes: A systematic review12
Long‐term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes11
Circulating adhesion molecules and associations withHbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study11
Depression as a predictor of hypoglycemia worry in parents of youth with recent‐onset type 1 diabetes11
Predictors of mood, diabetes‐specific and COVID ‐19‐specific experiences among parents of early school‐age children with type 1 diabetes during initial months of the11
Psychological care in children and adolescents with type 1 diabetes in a real‐world setting and associations with metabolic control11
Effects of advanced carbohydrate counting on glucose control and quality of life in children with type 1 diabetes11
Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data f11
Psychosocial outcomes in young adolescents with type 1 diabetes participating in shared medical appointments11
Association between high levels of physical activity and improved glucose control on active days in youth with type 1 diabetes11
Improved genetic risk scoring algorithm for type 1 diabetes prediction11
Educational outcomes among children with type 1 diabetes: Whole‐of‐population linked‐data study11
Diabetic neuropathy in children and youth: New and emerging risk factors11
Hemoglobin A1c trajectories in the first 18 months after diabetes diagnosis in the SWEET diabetes registry10
HbA1c percentiles and the association between BMI , age, gender, puberty, and HbA1c levels in healthy Germa10
Microalbuminuria and retinopathy in adolescents and young adults with type 1 and type 2 diabetes10
Performance of three different continuous glucose monitoring systems in children with type 1 diabetes during a diabetes summer camp10
Serum fatty acids and risk of developing islet autoimmunity: A nestedcase–controlstudy within theTRIGRbirth cohort10
Influence of social determinants of health barriers to family management of type 1 diabetes in Black single parent families: A mixed methods study10
Worldwide differences in childhood type 1 diabetes: TheSWEETexperience10
Long‐acting contraception in adolescents and young women with type 1 and type 2 diabetes10
Dual diagnosis of type 1 diabetes mellitus and attention deficit hyperactivity disorder10
Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes10
Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry10
Glycemic control in youth‐onset type 2 diabetes correlates with weight loss10
A pilotnon‐inferiorityrandomized controlled trial to assess automatic adjustments of insulin doses in adolescents with type 1 diabetes on multiple daily injections therapy10
Genotype‐phenotype correlation of K ATP channel gene defects causing permanent neonatal diabetes in Indian patients9
Type 1 diabetes incidence increased during the COVID ‐19 pandemic years 2020–2021 in Czechia: Results from a large population‐based pediatric register9
DYNAMIC: Dynamic glucose management strategies delivered through a structured education program improves time in range in a socioeconomically deprived cohort of children and young people with type 1 d9
Effects of family and neighborhood risks on glycemic control among young black adolescents with type 1 diabetes: Findings from a multi‐center study9
Initiating hybrid closed loop: A program evaluation of an educator‐led Control‐IQ follow‐up at a large pediatric clinic9
Measuring psychological flexibility in youth with type 1 diabetes9
Changes in pancreatic exocrine function in young at‐risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA study9
Poster Abstract9
The psychological profile of youth and young adults with type 1 diabetes in New Zealand9
Evaluation of HbA1c and glucose management indicator discordance in a population of children and adolescents with type 1 diabetes9
Risk factors for COVID ‐19‐related mortality in hospitalized children and adolescents with diabetes mellitus: An observational retrospective cohort study9
The association of low‐density lipoprotein cholesterol with elevated arterial stiffness in adolescents and young adults with type 1 and type 2 diabetes: The 9
Relationship of oxidative stress to visceral adiposity in youth and role played by vitamin D9
Clinical features, biochemistry, andHLA‐DRB1status in youth‐onset type 1 diabetes in Sudan8
Glycemic control is associated with dyslipidemia over time in youth with type 2 diabetes: The SEARCH for diabetes in youth study8
Family conflict in type 1 diabetes: Who is at risk?8
Characterization of youth goal setting in the self‐management of type 1 diabetes and associations with HbA1c: The Flexible Lifesty8
Predictors of glycemic control in children and adolescents with type 1 diabetes at 12 months after diagnosis8
A collaborative comparison of international pediatric diabetes registries8
Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well‐controlled youth with type 1 diabete8
Novel insights into diabetes mellitus due to DNAJC3 ‐ defect: Evolution of neurological and endocrine phenotype in t8
Pediatric diabetes in China: Challenges and actions8
Etiologies, trends, and predictors of 30‐day pediatric readmissions after hospitalizations for diabetic ketoacidosis in the United States8
Medical nutrition therapy of pediatric type 1 diabetes mellitus in India: Unique aspects and challenges8
Trajectory and predictors of HbA1c in children and adolescents with type 1 diabetes—A Danish nationwide cohort study8
Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study8
The accuracy of provider diagnosed diabetes type in youth compared to an etiologic criteria in the SEARCH for Diabetes in Youth Study8
Has subsidized continuous glucose monitoring improved outcomes in pediatric diabetes?8
Identification ofGCK‐maturity‐onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features8
Diabetic ketoacidosis incidence among children with new‐onset type 1 diabetes in Poland and its association with COVID ‐19 outbreak—Two‐year cross‐sectional national8
Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?8
Poster Abstracts8
0.063366174697876